Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-52.79%
0%
-52.79%
6 Months
-52.79%
0%
-52.79%
1 Year
-52.79%
0%
-52.79%
2 Years
-58.73%
0%
-58.73%
3 Years
-65.6%
0%
-65.6%
4 Years
-73.85%
0%
-73.85%
5 Years
-75.15%
0%
-75.15%
Oriola Corp. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
0.71%
EBIT Growth (5y)
-26.09%
EBIT to Interest (avg)
3.84
Debt to EBITDA (avg)
0.28
Net Debt to Equity (avg)
-0.56
Sales to Capital Employed (avg)
4.24
Tax Ratio
100.00%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.10%
ROCE (avg)
11.32%
ROE (avg)
4.12%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.24
EV to EBIT
77.88
EV to EBITDA
4.61
EV to Capital Employed
1.47
EV to Sales
0.05
PEG Ratio
NA
Dividend Yield
0.89%
ROCE (Latest)
1.89%
ROE (Latest)
-24.94%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
No Trend
No Trend
OBV
Mildly Bearish
Mildly Bullish
Shareholding Snapshot : Dec 2011
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 1 Foreign Institutions (0.1%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ
Jun'25
Mar'25
Change(%)
Net Sales
493.90
447.10
10.47%
Operating Profit (PBDIT) excl Other Income
1.60
6.00
-73.33%
Interest
1.30
1.60
-18.75%
Exceptional Items
0.00
0.00
Consolidate Net Profit
-5.60
-5.40
-3.70%
Operating Profit Margin (Excl OI)
-2.80%
-6.00%
0.32%
USD in Million.
Net Sales
QoQ Growth in quarter ended Jun 2025 is 10.47% vs 1.45% in Mar 2025
Consolidated Net Profit
QoQ Growth in quarter ended Jun 2025 is -3.70% vs 69.66% in Mar 2025
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
1,679.70
1,493.80
12.44%
Operating Profit (PBDIT) excl Other Income
23.30
27.30
-14.65%
Interest
8.70
9.20
-5.43%
Exceptional Items
-2.30
-21.70
89.40%
Consolidate Net Profit
-20.10
-20.70
2.90%
Operating Profit Margin (Excl OI)
6.90%
9.00%
-0.21%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 12.44% vs -2.94% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 2.90% vs -531.25% in Dec 2023
About Oriola Corp. 
Oriola Corp.
Retailing
Oriola Oyj, formerly known as Oriola-KD Corporation Oyj, is a Finland-based company active in the pharmaceutical sector. The Company is engaged in the retail and wholesale of pharmaceuticals, acting as a channel between pharmaceutical manufacturers and consumers, primarily in Finland and Sweden. The Company's reporting segments are Consumer, Services, and Healthcare. Through its own pharmacies, the Company provides consumers with not only medicines and pharmaceutical advice but also a selection of healthcare consumer products and customer service. The Company is active through a number of subsidiaries located throughout Europe, including PharmaService OY, Oriola AB, Oriola Oyj, Farenta Oy, Kronans Droghandel Apotek AB and Svensk dos AB.
Company Coordinates 
Company Details
Orionintie 5 , ESPOO None : 02200
Registrar Details






